Navigation Links
Avanir Pharmaceuticals Announces Appointment of Elona Kogan, Esq. as Vice President of Legal Affairs
Date:5/9/2011

ALISO VIEJO, Calif., May 9, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the appointment of Elona Kogan, Esq. to the position of vice president of legal affairs.

"At this time of growth and transition to a commercial stage biopharmaceutical company, Elona's legal, regulatory and business expertise will be a valuable asset to our organization," said Keith A. Katkin, president and CEO of Avanir. "The executive team and I are pleased to have Elona's extensive experience and expert counsel as we move ahead with our exciting new endeavors."

Ms. Kogan has over 17 years of experience covering areas of commercial and regulatory compliance, patient assistance programs, privacy issues, contracting, litigation and corporate governance. Most recently Ms. Kogan was associate general counsel and privacy officer at King Pharmaceuticals, where she was the primary legal liaison for corporate strategic and tactical commercial initiatives. Previously, Ms. Kogan was counsel for U.S. Medicines at Bristol-Myers Squibb. Prior roles included positions at Bergen Brunswig Corporation, and Epstein, Becker & Green. Ms. Kogan earned her J.D. degree from Southwestern University and her B.A. degree in Economics from Columbia University.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR™ is a trademark owned by Avanir Pharmaceuticals, Inc.

©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.


'/>"/>
SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Avanir Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference
2. Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
3. Avanir Pharmaceuticals to Present Data at the American Academy of Neurology Annual Meeting
4. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
5. Avanir Pharmaceuticals to Present at Three Conferences in March
6. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
7. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
8. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
9. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
10. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
11. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), ... company,s second affiliate in Latin America . ... ... Colombia ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
Breaking Medicine News(10 mins):